Cover Image

Critical Issues in Head and Neck Oncology Key Concepts from the Eighth THNO Meeting /

Show other versions (2)

This is an open access book. With a wealth of exciting data emerging in this rapidly evolving field this book will review the state-of-the-art knowledge with emphasis on multidisciplinary decision and management of head and neck cancer. The book provides significant detail on a wide range of topics...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Vermorken, Jan B. (Editor), Budach, Volker (Editor), Leemans, C. René (Editor), Machiels, Jean-Pascal (Editor), Nicolai, Piero (Editor), O'Sullivan, Brian (Editor)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2023.
Edition:1st ed. 2023.
Subjects:
Oncology.
Radiology.
Cancer > Treatment.
Cancer Therapy.
Online Access:Link to Metadata
Tags: Add Tag
No Tags, Be the first to tag this record!
Table of Contents:
  • The gut microbiota and anticancer immunotherapy, Laurence Zitvogel
  • The bidirectional communication between tumor cells and other components of the tumor microenvironment, Phil Sloan
  • Resistance mechanisms in immune checkpoint inhibitors and radiotherapy and how to overcome this, Kirsten Lauber
  • DNA repair mechanisms as a new target in head and neck cancer, Kevin Harrington
  • How to standardize molecular profiling programs for routine patient care, Ingeborg Tinhofer
  • Novel immune oncology targets beyond PD-1/PD-L1 in head and neck cancer, Christophe Le Tourneau
  • Analytic methods to understand head and neck cancer evolution to guide therapeutic approaches, Ben O'Leary
  • Clinical cases, Jean Pascal Machiels
  • Updates from the European Head & Neck Society (EHNS), Wojciech Golusinski (President of EHNS) Section 2: Primary disease Piero Nicolai
  • Sensitivity and specificity of extranodal extension in SCCHN: unlocking the strongest prognostic factor in head and neck cancer, Brian O'Sullivan
  • From photon to proton: what's in it for head and neck cancer patients?, Volker Budach
  • Lessons learned from RTOG 1016 and DE-ESCALaTE: what's next?, Hisham Mehanna.-Treatment intensification in LA-SCCHN: what are the options and for who?, Jan Vermorken
  • Immune checkpoint inhibitors in the curative setting: preclinical and clinical data, Jean-Pascal Machiels
  • Carcinoma of unknown primary: diagnostics and the potential of transoral surgery, René Leemans
  • Clinical cases, Volker Budach
  • Individualized therapy in 1-line R/M-SCCHN: what selection criteria should we use?, Petr Szturz
  • Patterns of response to immune oncology drugs: how relevant are they in SCCHN?, Amanda Psyrri
  • The role of radiotherapy in oligometastatic or oligoprogressive disease in R/M-SCCHN, Daan Nevens
  • Updates from the EORTC Head and Neck Cancer Group (HNCG), Jean-Pascal Machiels (Chair of EORTC-HNCG)
  • Real world evidence in head and neck cancer, Anil D'Cruz (UICC president
  • Pathology driven treatment of skull base tumors, Piero Nicolai
  • Modern day reconstruction of facial bones, Sat Parmar
  • Targeting molecular/minimal residual disease using novel technologies and clinical trials design, Lillian Siu
  • New developments in surgery for malignant salivary gland tumors, Jeroen Meulemans
  • New systemic therapies in salivary gland cancer, Ethan Argiris. Exercise and nutrition interventions in head and neck cancer, Paolo Bossi
  • Telehealth intervention in head and neck cancer patients: a promise?, Irma Verdonck-de Leeuw.

Similar Items